Chile In-Vitro Diagnostics Market is predicted to reach USD 263.3 Million by 2030

According to the study by Next Move Strategy Consulting, the Chile In-Vitro Diagnostics Market size is predicted to reach USD 263.3 million, at a CAGR of 5.2% by 2030.

Request a FREE Sample: https://www.nextmsc.com/chile-in-vitro-diagnostics-market/request-sample

The prevalence of chronic diseases such as cancer is notably higher in Chile compared to other Latin American countries, which is driving growth in the in-vitro diagnostics market.

The rising adoption of point-of-care diagnostics is further driving the Chile IVD market growth. One of the primary advantages of point-of-care testing (POCT) is its ability to deliver rapid results, administered by clinical staff.

The promising players operating in the Chile in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.